Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Pancreas Cancer
95%
Organoid
56%
Biological Marker
51%
Cancer Cell
41%
Fibroblast
39%
Neoplasm
36%
Personalized Medicine
35%
Electromagnetic Field
28%
Surgery
25%
Stroma
24%
Pancreatic Ductal Adenocarcinoma
22%
Treatment Response
22%
Malignant Neoplasm
21%
Specific Tumor
21%
Gene Expression Profiling
20%
Tumor Microenvironment
18%
Cell Proliferation
17%
Cancer Treatment
17%
Blood Culture
17%
Diagnosis
17%
Translational Research
17%
Recurrent Disease
17%
Immune-Related Adverse Events
17%
Targeted Therapy
17%
Immunoglobulin G
17%
Cancer Growth
17%
Hepatocellular Carcinoma
17%
Neoadjuvant Therapy
17%
Intensive Care Unit
17%
Breast Carcinoma
17%
Mesothelin
17%
Chimeric Antigen Receptor T-Cell
17%
Ex Vivo
17%
Chemotherapy
16%
Medicine
16%
Cancer Associated Fibroblast
14%
Immune Checkpoint Inhibitor
14%
Breast Cancer
13%
T Cell
12%
Growth Differentiation Factor 15
11%
In Vitro
11%
Biofeedback
9%
Buccal Drug Administration
9%
Transcriptomics
8%
Mouth Cavity
8%
Tumor Progression
8%
Epithelial Cell
8%
Immunohistochemistry
8%
Biopsy
7%
Keyphrases
Pancreatic Adenocarcinoma
53%
Pancreatic Ductal Adenocarcinoma
48%
Tumor Microenvironment
36%
Pancreatic Cancer
33%
Human Pancreatic Ductal Adenocarcinoma
26%
Microenvironment
23%
Patient-derived Organoids
19%
Fibroblasts
19%
Precision Medicine
17%
Change Analysis
17%
Anti-PD-1 Therapy
17%
Human Pancreatic Cancer
17%
Transcriptome Analysis
17%
Colorectal Cancer
17%
Prognostic Marker
17%
Incomplete Resection
17%
Multi-omics Analysis
17%
Pancreatic Cancer Organoids
17%
Polyphyllin I
17%
Tumor-specific Frequencies
17%
Amplitude Modulated
17%
Electromagnetic Field
17%
Sialylated IgG
17%
Neoantigen
17%
TGFBR1
17%
Human Breast Carcinoma
17%
Translational Research
17%
SNP
17%
Advanced Hepatocellular Carcinoma
17%
Dichotomous Key
17%
Neoadjuvant Therapy
17%
Pancreatic Cancer Progression
17%
Pharmacotyping
17%
Nivolumab
17%
Organoids
17%
Pancreas
17%
SMAD4
17%
Prevent Recurrence
17%
Allele-specific Expression
17%
Fibroblast Activation Protein
17%
Mesothelin
17%
Chimeric Antigen Receptor T Cells (CAR-T)
17%
Anti-CD3
17%
Tumor
16%
T Cells
16%
Overall Survival
13%
Transcriptomics
11%
Growth Differentiation factor-15 (GDF-15)
11%
Local Recurrence
10%
Cancer-associated Fibroblasts
10%
Immunology and Microbiology
Organoid
35%
Cancer Cell
35%
Fibroblast
26%
Vaccine Efficacy
26%
Gene Expression Profiling
21%
T Cell
20%
Mouse
18%
Immunoglobulin G
17%
Stroma
17%
Nivolumab
17%
Pancreas
17%
Retroposon
17%
Multi-Omics
17%
Phylogenetic Tree
17%
Polymerase Chain Reaction
17%
Lineages
17%
Genotype
17%
MAPK Signaling
17%
Neoantigen
17%
Alu Sequence
17%
Phylogeny
17%
Western Blot
17%
Cercopithecidae
17%
Platyrrhini
17%
Growth Differentiation Factor 15
11%
Prognostic Biomarker
10%
P53
8%
Overall Survival
8%
Breast Epithelium
8%
Transforming Growth Factor Beta
8%
Real Time Polymerase Chain Reaction
8%
Epigenetics
8%
Neutrophil Granulocyte
8%
Transcriptomics
8%
Cancer Associated Fibroblast
8%
Mediator
8%
T Cell Activation
8%
Neutrophil
8%
Lymph Node
7%
RNA Sequence
6%
Next Generation Sequencing
5%
Somatic Mutation
5%
